0 CHECKOUT

PRODUCT FILTERS

REGION

215
137
136
115
115

COUNTRY

107
22
22
15
15

PRICE

65
252
427
1,081

PUBLISHED

246
293
526
1,081

PRODUCT TYPE

1,020
58
2
1

Central Nervous System

In 2012 major changes might revolutionize the treatment of multiple sclerosis, as Gilenya, the first novel drug in five years, will be joined by three new products: BG-12, Aubagio, and Lemtrada. Recent exciting developments in drug discovery might also enhance the hopes of those fighting against Alzheimer.

Great commercial and scientific opportunities are to be found in similar battles against a range of diseases and neurodegenerative disorders, e.g. Parkinson’s disease, schizophrenia, migraine, insomnia, epilepsy, etc.

A wide selection of industry reports, scientific journals and academic textbooks in this section allow readers to explore every conceivable facet of this industry, such as market trends, industry forecasts, new drugs in development, the latest research & development, patent applications, and licensing strategies.

Key players featured in our publications include Biogen Idec, Sanofi, Genzyme, and many more. Show Less
Read more

Generalized Seizures-Pipeline Insights, 2016

“ Generalized Seizures-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Generalized Seizures. The report covers the product profiles...

Published:  February 2016
Price:  From

Chemotherapy Induced Peripheral Neuropathy-Pipeline Insights, 2016

“ Chemotherapy Induced Peripheral Neuropathy-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Chemotherapy Induced Peripheral Neuropathy....

Published:  February 2016
Price:  From

Autism-Pipeline Insights, 2016

“ Autism-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Autism. The report covers the product profiles in various stages of development...

Published:  February 2016
Price:  From

Acute Spinal Cord Injury-Pipeline Insights, 2016

“ Acute Spinal Cord Injury-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Acute Spinal Cord Injury. The report covers the product...

Published:  February 2016
Price:  From

Seizures-Pipeline Insights, 2016

“ Seizures-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Seizures. The report covers the product profiles in various stages...

Published:  February 2016
Price:  From

Partial Seizure-Pipeline Insights, 2016

“ Partial Seizure-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Partial Seizure. The report covers the product profiles in various...

Published:  February 2016
Price:  From

Meningococcal Meningitis-Pipeline Insights, 2016

“ Meningococcal Meningitis-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Meningococcal Meningitis. The report covers the product...

Published:  February 2016
Price:  From

Lewy body Dementia-Pipeline Insights, 2016

“ Lewy body Dementia-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Lewy body Dementia. The report covers the product profiles...

Published:  February 2016
Price:  From

Leber's Hereditary Optic Neuropathy (LHON) (Leber optic atrophy)-Pipeline Insights, 2016

“ Leber’s Hereditary Optic Neuropathy (LHON) (Leber optic atrophy)-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Leber’s Hereditary...

Published:  February 2016
Price:  From

Spinal Stenosis-Pipeline Insights, 2016

“ Spinal Stenosis-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Spinal Stenosis. The report covers the product profiles in various...

Published:  February 2016
Price:  From

Spinal Muscular Atrophy (SMA)-Pipeline Insights, 2016

“ Spinal Muscular Atrophy (SMA)-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Spinal Muscular Atrophy (SMA). The report covers...

Published:  February 2016
Price:  From

Brain Injury-Pipeline Insights, 2016

“ Brain Injury-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Brain Injury. The report covers the product profiles in various...

Published:  February 2016
Price:  From

Brain Hemorrhage-Pipeline Insights, 2016

“ Brain Hemorrhage-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Brain Hemorrhage. The report covers the product profiles in...

Published:  February 2016
Price:  From

Tourette Syndrome-Pipeline Insights, 2016

“ Tourette Syndrome-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Tourette Syndrome. The report covers the product profiles...

Published:  February 2016
Price:  From

Peripheral Neuropathy (Sensory Neuropathy)-Pipeline Insights, 2016

“ Peripheral Neuropathy (Sensory Neuropathy)-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Peripheral Neuropathy (Sensory Neuropathy)....

Published:  February 2016
Price:  From

Generalized Tonic-Clonic Seizure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Generalized Tonic-Clonic Seizure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales,...

Published:  February 2016
Price:  From

Brain Hemorrhage-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Brain Hemorrhage-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  February 2016
Price:  From

Absence Seizure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Absence Seizure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  February 2016
Price:  From

Herpes Simplex Encephalitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Herpes Simplex Encephalitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase...

Published:  February 2016
Price:  From

Epilepsy-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Epilepsy-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs...

Published:  February 2016
Price:  From
Loading Indicator

Our Clients